<DOC>
	<DOCNO>NCT01206322</DOCNO>
	<brief_summary>Our goal determine acute effect intranasal insulin regional perfusion cognition old adult . We propose pilot study examine effect single dose intranasal insulin regional vasoreactivity cognitive function 30 subject T2DM 30 healthy control &gt; 50 year old use double blind , placebo-controlled , cross-over design . Hypothesis 1 : Intranasal insulin improve acutely regional perfusion vasoreactivity old patient T2DM compare placebo compare control group . Hypothesis 2 : Intranasal insulin improves cognitive function include attention , memory executive function diabetic patient compare placebo compare control group .</brief_summary>
	<brief_title>Enhancement Cerebral Vasoreactivity Cognition Intranasal Insulin Type 2 Diabetes</brief_title>
	<detailed_description>Type 2 diabetes mellitus ( T2DM ) major risk factor vascular dementia . DM alters insulin transport across blood-brain barrier affect perfusion neuronal function . Intranasal administration enables effective delivery insulin brain . Clinical study demonstrate improvement cognitive function memory healthy cognitively impaired people . Aim 1 : To determine acute effect single 40-IU dose intranasal insulin vs. placebo regional perfusion vasoreactivity CO2 challenge measure 3-D continuous arterial spin labeling ( CASL ) MRI 3 Tesla control diabetic group . We use transcranial Doppler determine effect intranasal insulin vs. placebo cerebral autoregulation base measurement beat-to-beat pressure flow velocity relationship . Aim 2 : To determine whether intranasal insulin improve cognitive function old T2DM patient compare placebo control group . This translational study address important area effect intranasal insulin cerebral blood flow regulation cognition old diabetic study . Intranasal insulin administration may provide novel therapeutic target prevention treatment microvascular disease cerebrovascular complication T2DM . If successful , approach may significant impact clinical management large population old adult T2DM .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Diabetes group : 30 men woman age &gt; 50 year old diagnose T2DM treat &gt; 5 year oral agent Diabetes severity assess diabetes duration , hemoglobin A1C , fast glucose level . Control group : 30 healthy men woman age &gt; 50 year select age sex distribution diabetic subject Normotensive , treat systemic disease , normal fast blood glucose . Type 1 Diabetes Mellitus History severe hypoglycemia hypoglycemic episode home baseline monitor Positive stress test CAD ischemic condition Carotid stenosis &gt; 50 % medical history History clinically document stroke Treatment medication administer intranasally include intranasal steroid Any previous adverse allergic reaction insulin Acute unstable medical condition include Myocardial infarction major illness surgery within six month Liver renal failure transplant Uncontrolled hypertension ( systolic BP &gt; 180 and/or diastolic BP &gt; 100 mm Hg subject take 3 antihypertensive medication ) Seizure disorder Malignant tumor Clinical dementia ( history ) inability follow detail protocol ( MMSE ( Mini Mental Status Exam ) score ( ≥3 point Comparative Normal Value subject 's age group education level , ≤ 24 ) Current recreational drug alcohol abuse Morbid obesity ( BMI &gt; 40 ) Inability obtain permission participation primary care physician Transcranial Doppler ( TCD ) exclusion criterion poor insonation window TCD signal MR exclusion criterion metal bioimplants compatible 3 Tesla MRI claustrophobia Clinically significant movement limit hip , knee and/or back disorder injury , rheumatoid arthritis</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>diabetes , blood flow , brain perfusion , cognitive function</keyword>
</DOC>